Introduction
Cytomegalovirus is responsible for a significant percentage of asymptomatic viral infections. Virtually any cell or organ may be infected (1) . CMV infection occurs frequently worldwide and CMV seroprevalence is estimated to range between 60% to above 90% in developed countries, with even higher rates (>90%) in developing countries (2, 3) . Bulgarian blood donors were seropositive at a total of 96.7% and 83.5% for EBV / CMV respectively (4).
During childhood, many people acquire primary infection with cytomegalovirus and if they later become immunosuppressed, CMV is likely to become reactivated (5,; 6) . The effects of human CMV on cellular functions which may be associated with the malignant phenotype include the expression of oncogenes (7).
Melnick and co-workers discuss the association of CMV and a variety of malignancies and conclude that CMV is an important component of tumorigenesis (8) . In primary infection, EBV infects B cells and can cause mucocutaneous manifestations in infectious mononucleosis or acute EBV-associated syndromes such as Gianotti-Crosti syndrome and hemophagocytic syndrome (3, 9, 10) .
A latent EBV infection may result in diseases and lymphoproliferative disorders such as plasmablastic lymphoma, oral hairyleukoplakia, and post-transplant lymphoproliferative disorders. Latent EBV infection has also been implicated in Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and Kikuchi histocytic necrotizing lymphadenitis (9, 11).
These two herpesviruses also affects largely the oral structures, resulting in different oral manifestations, lesions and complications in the oral cavity -benign and malignant (2) .
Aim
The aim of the present study was to evaluate the prevalence of Epstein-Barr virus and cytomegalovirus in Bulgarian dental patients.
Material and Methods
We decided to inverstigate the presence of Epstein-Barr virus and cytomegalovirus in consecutive dental patients, who sought dental care in the Department of Oral and Imaging Diagnostics, Faculty of Dental Medicine, Medical University, Sofia, from April 2014 to July 2016.
116 patients participated in the study -35 males and 81 females, with an average age for the group 49.3 ± sd 13.9 years. All the patients underwent oral examination. The clinical findings were common oral pathology, common superficial oral lesions, without any maxilla-facial malignancy. None of the participants showed data of any malignancy in any part of the body.
Epstein-Barr Virus Antibody to Viral Capsid Antigen IgM ( anti-VCA IgM), Epstein-Barr Virus Antibody to Viral Capsid Antigen IgG (anti-VCA IgG), Epstein-Barr nuclear antigen IgG (anti-EBNA IgG) and CMV IgM were evaluated using the immunochemical technique ELFA (Enzyme-linked Immunofluorescence assay).
The results are present in Tabl.1. 
Results

Tabl. 1. Serum levels of CMV and EBV antibodies in consecutive dental
CMV-IgM
We mesured the avarage value of IgM antibody to CMV for all groups of dental patients 0,292 ± 0.143 U (Tabl. 1). Values above the normal range are 2.8% (Tabl. 2).
By analyzing the results by gender we established that he elevated values are more pronounced in male patients.
Fig. 1. CMV-IgM serum levels in consecutive female dental patients
Fig. 2. CMV-IgM serum levels in consecutive male dental patients
In female patients the positive IgM antibody to CMV is 2, 6% ( Fig.1 ), compared to the positive results in males that amount to 3,20% (Fig. 2) . Acute infection of CMV for all groups is seen in 2,8% ( The positive results of IgG EBNA indicated a past infection of EBV or reactivation of the virus. In 92% of male patients we detected abnormally increased values of anti EBNA IgG (Fig. 8) . In female dental patients anti EBNA IgG were elevated in 95% (Fig. 7) . Presence of VCA IgM antibodies indicates recent primary infection with Epstein-Barr virus. In our study VCA IgM antibodies were incresed in 6% of the patients.
Discussion
Positive VCA-IgG was detected in almost 97 % of all tested dental patients and this reveals that the person has a current or recent EBV infection and they have inactivation of the virus (Tabl. 2).
Antibodies to EBNA develop 6 to 8 weeks after primary infection and are detectable for life. Over 90% of the normal adult population has IgG class antibodies to VCA and EBNA. 95% of our dental patients were with elevated values. The elevated titer of EBNA IgG reveals the degree of reactivation of the virus.
In our patients we detected 97% and 95% higher values of anti VCA IgG and anti EBNA IgG respectively, which reflect a chronic infection with the virus. The 2% of difference between the patients with elevated VCA IgG and negative EBNA IgG is probably due to an acute infection of EBV. In 6 % we detected elevated VCA-IgM. So the acute EBV infection is detected in 8% of the investigated dental patients.
Co-infection with cytomegalovirus and Epstein-Barr virus
We detected acute infection to CMC in 2.8% and to EBV in 6%. We didn't find coinfection with these two viruses.
In the medical literatute there are reports concerning co-infection with cytomegalovirus and Epstein-Barr virus. D. Olson and co-workers found elevated IgM titres to both CMV and EBV in young women. Both near-simultaneous infections and temporally remote sequential infections with acute CMV triggering an immunoreactivation of EBV are reported in the literature. Recognizing that coinfection with these viruses may modulate the clinical course of disease is important (13, 14) .
In 208 renal transplantation patients CMV and EBV replications were observed in 22% and 19%. In our dental patients we found 3 % of acute CMV and 6% of acute EBV (Tabl. 1). Many of these active virus infections were found to overlap in time (59% and 74% of all active CMV and EBV infections, respectively) (15).
EBV and CMV in parodontitis and healthy sites
Recent investigations suggest that the viruses of the family Herpesviridae are associated with periodontal disease (16, 17, 18 ).
Hernández and co-workers detected CMV in 27.3% of aggressive periodontitis patients, but it was not detected in the chronic form and in healthy subjects (17) . Compared to our result we detected that 2,8 % of our patients were with acute CMV. The % is low and one of the explanations is that our patients were with controlled periodontal health.
R. Sharma et al. described the prevalence of CMV and EBV-1 in 45% of cases with aggressive periodontitis. Prevalence of CMV in chronic periodontitis was 20% and in healthy subjects 10%, while for EBV-1 it was 25% and 0%, respectively. The virus positive sites showed higher pocket depth compared to virus negative sites (18) .
Using saliva as a diagnostic tool, Leon Bilder and co-workers inverstigated CMV in unstimulated saliva and found that chronic periodontitis patients had higher prevalence of CMV and suggested that CMV may play a role in the pathogenesis of chronic periodontitis (16) .
Another study reveals that CMV can be found not only at the disease sites, bu also at the healthy sites in periodontitis patients (19) . CMV was found in one healthy control while HHV-6 and EBV-1 were not found (19) . Hengameh Khosropanah identifies CMV and EBV in saliva. The conclusion of the study was that the highest CMV count was in saliva and tissue samples with PD > 6 mm (20) . In our patients we used serum for the detection of the CMV and EBV.
Conclusion
This is the first report concerning the prevalence of Epstein-Barr virus and cytomegalovirus in Bulgarian dental patients. The majority of dental patients (95%) have chronic infection of EBV. 8 % have acute infection of EBV and 2,8% of CMV. Coinfections with EBV and CMV were not present in our patients.
